{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:17:27Z","timestamp":1788412647492,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL136318"],"award-info":[{"award-number":["U01 HL136318"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"DOI":"10.1038\/s41372-026-02889-2","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:51:45Z","timestamp":1788411105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of iron sufficiency in premature infants treated with darbepoetin using conventional and novel erythrocyte metrics"],"prefix":"10.1038","author":[{"given":"Natalie","family":"Bishara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7946-0290","authenticated-orcid":false,"given":"Timothy M.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Woodbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-582X","authenticated-orcid":false,"given":"Robert D.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2865-8878","authenticated-orcid":false,"given":"Robin K.","family":"Ohls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2889_CR1","doi-asserted-by":"crossref","unstructured":"Ohls RK. Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants. Semin. Fetal. Neonatal. Med. 2026:101718.","DOI":"10.1016\/j.siny.2026.101718"},{"key":"2889_CR2","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41372-025-02225-0","volume":"45","author":"SM Tweddell","year":"2025","unstructured":"Tweddell SM, Morelli TM, Bahr TM, Krueger A, Christensen RD, Ohls RK. Identifying barriers to complying with new restrictive NICU transfusion guidelines. J Perinatol. 2025;45:1820\u20134.","journal-title":"J Perinatol"},{"key":"2889_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2024.101545","volume":"30","author":"RK Ohls","year":"2025","unstructured":"Ohls RK, Bahr TM, Peterson TG, Christensen RD. A practical guide to reducing\/eliminating red blood cell transfusions in the neonatal intensive care unit. Semin Fetal Neonatal Med. 2025;30:101545.","journal-title":"Semin Fetal Neonatal Med"},{"key":"2889_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamapediatrics.2025.0807","volume":"179","author":"RK Ohls","year":"2025","unstructured":"Ohls RK, Das A, Tan S, Lowe JR, Schibler K, Beauman SS, et al. Darbepoetin, red cell mass, and neuroprotection in preterm infants: a randomized clinical trial. JAMA Pediatr. 2025;179:836\u201345.","journal-title":"JAMA Pediatr"},{"key":"2889_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41372-025-02247-8","volume":"45","author":"TM Bahr","year":"2025","unstructured":"Bahr TM, Christensen RD, Weaver-Lewis KA, Scott DM, Gerday E, Tuttle JJ, et al. A prospective randomized pilot trial comparing weekly vs. biweekly Darbepoetin administration to preterm infants. J Perinatol. 2025;45:951\u20136.","journal-title":"J Perinatol"},{"key":"2889_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jaapos.2017.03.006","volume":"21","author":"H Erd\u00f6l","year":"2017","unstructured":"Erd\u00f6l H, Hacioglu D, Kola M, T\u00fcrk A, Aslan Y. Investigation of the effect of hemoglobin F and A levels on development of retinopathy of prematurity. J AAPOS. 2017;21:136\u201340.","journal-title":"J AAPOS"},{"key":"2889_CR7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/eye.2017.76","volume":"31","author":"CJ Stutchfield","year":"2017","unstructured":"Stutchfield CJ, Jain A, Odd D, Williams C, Markham R. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study. Eye (Lond). 2017;31:1451\u20135.","journal-title":"Eye (Lond)"},{"key":"2889_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41372-018-0274-9","volume":"39","author":"C Lust","year":"2019","unstructured":"Lust C, Vesoulis Z, Jackups R Jr, Liao S, Rao R, Mathur AM, et al. Early red cell transfusion is associated with development of severe retinopathy of prematurity. J Perinatol. 2019;39:393\u2013400.","journal-title":"J Perinatol"},{"key":"2889_CR9","doi-asserted-by":"publisher","first-page":"e0234266","DOI":"10.1371\/journal.pone.0234266","volume":"15","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Hua X, Yu Y, Zhu P, Hong K, Ke Y. Effect of red blood cell transfusion on the development of retinopathy of prematurity: A systematic review and meta-analysis. PLoS One. 2020;15:e0234266.","journal-title":"PLoS One"},{"key":"2889_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41433-020-0938-5","volume":"35","author":"K Jiramongkolchai","year":"2021","unstructured":"Jiramongkolchai K, Repka MX, Tian J, Aucott SW, Shepard J, Collins M, et al. Lower foetal haemoglobin levels at 31- and 34-weeks post menstrual age is associated with the development of retinopathy of prematurity: PacIFiHER Report No. 1 PacIFiHER Study Group (Preterm Infants and Fetal Haemoglobin in ROP). Eye (Lond). 2021;35:659\u201364.","journal-title":"Eye (Lond)"},{"key":"2889_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/bjophthalmol-2021-319546","volume":"107","author":"K Jiramongkolchai","year":"2023","unstructured":"Jiramongkolchai K, Repka MX, Tian J, Aucott SW, Shepard J, Collins M, et al. Effects of fetal haemoglobin on systemic oxygenation in preterm infants and the development of retinopathy of prematurity PacIFiHER Report No. 2. Br J Ophthalmol. 2023;107:380\u20133. PacIFiHER study group (preterm infants and foetal haemoglobin in retinopathy of prematurity).","journal-title":"Br J Ophthalmol"},{"key":"2889_CR12","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.4103\/IJO.IJO_692_23","volume":"71","author":"N Prasad","year":"2023","unstructured":"Prasad N, Kumar K, Dubey A. Fetal hemoglobin, blood transfusion, and retinopathy of prematurity in preterm infants: An observational, prospective study. Indian J Ophthalmol. 2023;71:2803\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"2889_CR13","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/apa.16965","volume":"112","author":"K Glaser","year":"2023","unstructured":"Glaser K, H\u00e4rtel C, Dammann O, Herting E, Andres O, Speer CP, et al. German Neonatal Network. Erythrocyte transfusions are associated with retinopathy of prematurity in extremely low gestational age newborns. Acta Paediatr. 2023;112:2507\u201315.","journal-title":"Acta Paediatr"},{"key":"2889_CR14","doi-asserted-by":"publisher","first-page":"S537","DOI":"10.4103\/IJO.IJO_2919_23","volume":"72","author":"H Daungsupawong","year":"2024","unstructured":"Daungsupawong H, Wiwanitkit V. Fetal hemoglobin in the development and progression of retinopathy of prematurity in preterm infants: Comment. Indian J Ophthalmol. 2024;72:S537\u2013S538.","journal-title":"Indian J Ophthalmol"},{"key":"2889_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/biomedicines13010110","volume":"13","author":"M Fevereiro-Martins","year":"2025","unstructured":"Fevereiro-Martins M, Aguiar L, In\u00e1cio \u00c2, Cardoso C, Santos AC, Marques-Neves C, et al. GenE-ROP Study Group. Fetal hemoglobin as a predictive biomarker for retinopathy of prematurity: A prospective multicenter cohort study in Portugal. Biomedicines. 2025;13:110.","journal-title":"Biomedicines"},{"key":"2889_CR16","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1038\/s41372-025-02368-0","volume":"45","author":"RD Christensen","year":"2025","unstructured":"Christensen RD, Bahr TM, Ilstrup SJ, Hartnett ME, Ohls RK. Involving neonatal hematology and transfusion medicine in global efforts to eliminate severe retinopathy of prematurity. J Perinatol. 2025;45:1839\u201347.","journal-title":"J Perinatol"},{"key":"2889_CR17","doi-asserted-by":"publisher","unstructured":"Zeiler BB, Hartnett ME, Addams JL, Stone EF, Ilstrup SJ, Bahr TM, et al. Transfusion histories of neonates who developed severe retinopathy of prematurity. Neonatology. 2026:1-9. https:\/\/doi.org\/10.1159\/000551673.","DOI":"10.1159\/000551673"},{"key":"2889_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/14767058.2013.830836","volume":"26","author":"A Del Vecchio","year":"2013","unstructured":"Del Vecchio A, Henry E, D\u2019Amato G, Canuso A, Corriero L, Motta M, et al. Instituting a program to reduce the erythrocyte transfusion rate was accompanied by reductions in the incidence of bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2013;26:77\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2889_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep04340","volume":"4","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Huang X, Lu H. Association between red blood cell transfusion and bronchopulmonary dysplasia in preterm infants. Sci Rep. 2014;4:4340.","journal-title":"Sci Rep"},{"key":"2889_CR20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0036-1597995","volume":"34","author":"S Ghirardello","year":"2017","unstructured":"Ghirardello S, Dusi E, Corti Novis I, Villa S, Fumagalli M, Agosti M, et al. Red blood cell transfusions on the risk of developing complications or death: an observational study of a cohort of very low birth weight infants. Am J Perinatol. 2017;34:88\u201395.","journal-title":"Am J Perinatol"},{"key":"2889_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/trf.15216","volume":"59","author":"RM Patel","year":"2019","unstructured":"Patel RM, Knezevic A, Yang J, Shanvi N, Hinkes M, Roback JD, et al. Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants. Transfusion. 2019;59:1675\u201382.","journal-title":"Transfusion"},{"key":"2889_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1095889","volume":"11","author":"L Tang","year":"2023","unstructured":"Tang L, Zhu TT, Zhao J. Association between red blood cell transfusion and bronchopulmonary dysplasia: a systematic review and meta-analysis. Front Pediatr. 2023;11:1095889.","journal-title":"Front Pediatr"},{"key":"2889_CR23","doi-asserted-by":"publisher","first-page":"e1499","DOI":"10.1055\/a-2051-8245","volume":"41","author":"F Bolat","year":"2024","unstructured":"Bolat F, Dursun M, Sariadin M. Packed red blood cell transfusion as a predictor of moderate-severe bronchopulmonary dysplasia: a comparative cohort study of very preterm infants. Am J Perinatol. 2024;41:e1499\u2013e1507.","journal-title":"Am J Perinatol"},{"key":"2889_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2023.113836","volume":"265","author":"TM Bahr","year":"2024","unstructured":"Bahr TM, Snow GL, Christensen TR, Davenport P, Henry E, et al. Can red blood cell and platelet transfusions have a pathogenic role in bronchopulmonary dysplasia? J Pediatr. 2024;265:113836.","journal-title":"J Pediatr"},{"key":"2889_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-025-07945-x","volume":"25","author":"C Niu","year":"2025","unstructured":"Niu C, Wu H, Lin Z, Li X, Dang D, Mu X. Association of early postnatal decline in fetal hemoglobin with bronchopulmonary dysplasia in very low birth weight infants: a cohort study. BMC Pregnancy Childbirth. 2025;25:864.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2889_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41372-024-02135-7","volume":"45","author":"TM Bahr","year":"2025","unstructured":"Bahr TM, Ohls RK, Henry E, Davenport P, Ilstrup SJ, Kelley WE, et al. The number of blood transfusions received and the incidence and severity of chronic lung disease among NICU patients born >31 weeks gestation. J Perinatol. 2025;45:218\u20133.","journal-title":"J Perinatol"},{"key":"2889_CR27","volume":"17","author":"A Al-Matari","year":"2025","unstructured":"Al-Matari A, AlShalan I, Aldair FM, Almujahid M, Almaza A. Exploring the relationship between blood transfusions and development of bronchopulmonary dysplasia in neonates. Cureus. 2025;17:e80706.","journal-title":"Cureus"},{"key":"2889_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12887-025-05797-0","volume":"25","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Lu S, Fang X, Zhang H. Red blood cell transfusion frequency and the risk and severity of bronchopulmonary dysplasia in preterm infants: a retrospective cohort study. BMC Pediatr. 2025;25:679.","journal-title":"BMC Pediatr"},{"key":"2889_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/archdischild-2020-319181","volume":"106","author":"W Hellstr\u00f6m","year":"2021","unstructured":"Hellstr\u00f6m W, Martinsson T, Hellstrom A, Morsing E, Ley D. Fetal haemoglobin and bronchopulmonary dysplasia in neonates: an observational study. Arch Dis Child Fetal Neonatal Ed. 2021;106:88\u201392.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2889_CR30","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/bjophthalmol-2020-318293","volume":"106","author":"W Hellstr\u00f6m","year":"2022","unstructured":"Hellstr\u00f6m W, Martinsson T, Morsing E, Gr\u00e4nse L, Ley D, Hellstr\u00f6m A. Low fraction of fetal haemoglobin is associated with retinopathy of prematurity in the very preterm infant. Br J Ophthalmol. 2022;106:970\u20134.","journal-title":"Br J Ophthalmol"},{"key":"2889_CR31","first-page":"627","volume":"12","author":"C Dani","year":"2025","unstructured":"Dani C, Remaschi G, Ulivi M, Monti N, Pratesi S. Fetal hemoglobin in preterm infants after resuscitation with immediate cord clamping, delayed cord clamping, or cord milking. Children (Basel). 2025;12:627.","journal-title":"Children (Basel)"},{"key":"2889_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/archdischild-2024-327411","volume":"110","author":"T Ulinder","year":"2025","unstructured":"Ulinder T, Hellstr\u00f6m W, Gadsb\u00f8ll C, Nilsson L, Gebka M, Robertz G, et al. Fetal haemoglobin and oxygen requirement in preterm infants: an observational study. Arch Dis Child Fetal Neonatal Ed. 2025;110:285\u201390.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2889_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2026.2614192","volume":"39","author":"C Dani","year":"2026","unstructured":"Dani C, Remaschi G, Ulivi M, Monti N, Pratesi S. Fetal hemoglobin fraction is correlated to the risk of prematurity complications. J Matern Fetal Neonatal Med. 2026;39:2614192.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2889_CR34","first-page":"117","volume":"13","author":"C Dani","year":"2026","unstructured":"Dani C, Cipriani F, Ciavotta M, Remaschi G. Changes in fetal hemoglobin in very preterm infants born small for gestational age: a retrospective observational study. Children (Basel). 2026;13:117.","journal-title":"Children (Basel)"},{"key":"2889_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103426","volume":"87","author":"L Teofili","year":"2025","unstructured":"Teofili L, Papacci P, Pellegrino C, Dani C, Cresi F, Remaschi G, et al. Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial. EClinicalMedicine. 2025;87:103426.","journal-title":"EClinicalMedicine"},{"key":"2889_CR36","doi-asserted-by":"crossref","unstructured":"Gelaw Y, Woldu B, Melku M. The role of reticulocyte hemoglobin content for diagnosis of iron deficiency and iron deficiency anemia, and monitoring of iron therapy: a literature review. Clin Lab. 2019;65.","DOI":"10.7754\/Clin.Lab.2019.190315"},{"key":"2889_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cca.2020.01.032","volume":"504","author":"C Ogawa","year":"2020","unstructured":"Ogawa C, Tsuchiya K, Maeda K. Reticulocyte hemoglobin content. Clin Chim Acta. 2020;504:138\u201345.","journal-title":"Clin Chim Acta"},{"key":"2889_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1515\/CCLM.2008.109","volume":"46","author":"E M\u00e4kel\u00e4","year":"2008","unstructured":"M\u00e4kel\u00e4 E, Takala TI, Suominen P, Matom\u00e4ki J, Salmi TT, Rajam\u00e4ki A, et al. Hematological parameters in preterm infants from birth to 16 weeks of age with reference to iron balance. Clin Chem Lab Med. 2008;46:551\u20137.","journal-title":"Clin Chem Lab Med"},{"key":"2889_CR39","doi-asserted-by":"publisher","first-page":"F198","DOI":"10.1136\/archdischild-2014-306076","volume":"100","author":"L Lorenz","year":"2015","unstructured":"Lorenz L, Arand J, B\u00fcchner K, Wacker-Gussmann A, Peter A, Poets CF, et al. Reticulocyte haemoglobin content as a marker of iron deficiency. Arch Dis Child Fetal Neonatal Ed. 2015;100:F198\u2013202.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2889_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000450674","volume":"111","author":"L Lorenz","year":"2017","unstructured":"Lorenz L, Peter A, Arand J, Springer F, Poets CF, Franz AR. Reference ranges of reticulocyte haemoglobin content in preterm and term infants: a retrospective analysis. Neonatology. 2017;111:189\u201394.","journal-title":"Neonatology"},{"key":"2889_CR41","doi-asserted-by":"publisher","first-page":"24650","DOI":"10.1159\/000477124","volume":"112","author":"L Lorenz","year":"2017","unstructured":"Lorenz L, Peter A, Arand J, Springer F, Poets CF, Franz AR. Reticulocyte Haemoglobin content declines more markedly in preterm than in term infants in the first days after birth. Neonatology. 2017;112:24650.","journal-title":"Neonatology"},{"key":"2889_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/jp.2015.140","volume":"36","author":"RD Christensen","year":"2016","unstructured":"Christensen RD, Henry E, Bennett ST, Yaish HM. Reference intervals for reticulocyte parameters of infants during their first 90 days after birth. J Perinatol. 2016;36:61\u20136.","journal-title":"J Perinatol"},{"key":"2889_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41372-020-00845-2","volume":"41","author":"TM Bahr","year":"2021","unstructured":"Bahr TM, Baer VL, Ohls RK, Christensen TR, Ward DM, Bennett ST, et al. Reconciling markedly discordant values of serum ferritin versus reticulocyte hemoglobin content. J Perinatol. 2021;41:619\u201326.","journal-title":"J Perinatol"},{"key":"2889_CR44","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/s41372-023-01751-z","volume":"43","author":"TM Bahr","year":"2023","unstructured":"Bahr TM, Tan S, Smith E, Beauman SS, Schibler KR, Grisby CA, et al. Serum ferritin values in neonates <29 weeks\u2019 gestation are highly variable and do not correlate with reticulocyte hemoglobin content. J Perinatol. 2023;43:1368\u201373.","journal-title":"J Perinatol"},{"key":"2889_CR45","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41372-025-02251-y","volume":"45","author":"TM Bahr","year":"2025","unstructured":"Bahr TM, Doyle K, Ohls RK, Christensen RD. Using the refineR algorithm to generate indirect reference intervals for newborn infants for the parameters \u201cMicro-R\u201d and \u201cHYPO-He. J Perinatol. 2025;45:1624\u20136.","journal-title":"J Perinatol"},{"key":"2889_CR46","doi-asserted-by":"publisher","unstructured":"Husain AN, Drury A, Swenson EA, Metcalf RA, Cail K, Kawamoto K, et al. Designing and implementing a clinical decision support tool to improve compliance with NICU transfusions. J Perinatol. 2026. https:\/\/doi.org\/10.1038\/s41372-026-02637-6.","DOI":"10.1038\/s41372-026-02637-6"},{"key":"2889_CR47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.clp.2023.07.009","volume":"50","author":"R Rao","year":"2023","unstructured":"Rao R, Georgieff MK. Anemia, iron supplementation, and the brain. Clin Perinatol. 2023;50:853\u201368.","journal-title":"Clin Perinatol"},{"key":"2889_CR48","doi-asserted-by":"crossref","unstructured":"Georgieff MK. The Effects of maternal iron deficiency and iron deficiency anemia on the developing fetal and neonatal brain. J Obstet Gynaecol Can. 2026:103269.","DOI":"10.1016\/j.jogc.2026.103269"},{"key":"2889_CR49","doi-asserted-by":"crossref","unstructured":"Hulse WN, Bahr TM, Ostrander B, Winter S, Ohls RK, DuPont TL. Iron Deficiency Screening with Reticulocyte-Hemoglobin Content and 2-Year Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants. Am J Perinatol. 2026.","DOI":"10.1055\/a-2806-3017"},{"key":"2889_CR50","doi-asserted-by":"crossref","unstructured":"Mueller G, Vitavew M, Robinson R, Sabo R, Henricks-Munoz K. Association between reticulocyte hemoglobin content (RetHe) and neurodevelopmental outcomes in preterm infants. J Perinatol. 2026. Epub ahead of print.","DOI":"10.1038\/s41372-026-02768-w"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02889-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02889-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:51:54Z","timestamp":1788411114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02889-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":50,"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02889-2","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The protocol for conducting this retrospective, deidentified, records review was approved by the Intermountain Health Institutional Review Board with a waiver of informed consent (IRB # 1051298). All methods were performed in accordance with United States Department of Health and Human Services regulations, including the Health Insurance Portability and Accountability Act (HIPAA) and the Federal Policy for the Protection of Human Subjects (Common Rule, 45 CFR 46).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}